Oral Abstract: ALL-300 First Report of PhALLCON: A Phase 3 Study Comparing Ponatinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia

Autor:	Jabbour, Elias *, Kantarjian, Hagop, Aldoss, Ibrahim, Montesinos, Pau, Leonard, Jessica, Gomez-Almaguer, David, Baer, Maria, Gambacorti-Passerini, Carlo, McCloskey, James, Minami, Yosuke, Papayannidis, Cristina, Rocha, Vanderson, Rousselot, Philippe, Vachhani, Pankit, Wang, Eunice, Hennessy, Meliessa, Patel, Niti, Vorog, Alexander, Wang, Bingxia, Yeh, Tammie, Ribera, Jose-Maria
Zdroj:	In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 1:S145-S145
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect